Our infectious disease pipeline features innovative diagnostic and therapeutic radiopharmaceuticals designed to:

1. Enable rapid, precise diagnosis of various pathogenic infections
2. Deliver personalized treatments tailored to each patient’s needs

These transformative technologies are especially critical for emerging infectious diseases and bioterrorism threats, where prompt, accurate detection and tailored care can be the difference between life and death.

By revolutionizing the standard of detection and treatment, we aim to curb outbreaks and save lives through our advanced diagnostic tools and personalized patient care approaches. This specialized portfolio reflects our commitment to addressing some of the most pressing global health challenges.